Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreCon el objetivo de determinar si el aumento del tamaño de los axones puede ser un biomarcador temprano de la esclerosis múltiple se ha dirigido un estudio en el que han conseguido detectar el daño...
Read moreThe Clinical and Epidemiological Neuroscience Research Group (NeuroEpia) of the Pere Virgili Health Research Institute (IISPV) will lead an international project to study the influence of nuts and esp...
Read moreThe defect in inhibitory neurons causes a distortion of reality in the brains of individuals with schizophrenia and can explain the majority of the symptoms of the disease, both cognitive and emotiona...
Read moreThe European Commission has accepted the EBRAINS 2.0 proposal, granting 38 million euros to continue developing the services of the EBRAINS research infrastructure, focused on the creation of digital ...
Read moreThe hospital is launching a second scientific study with a group of 6 new patients to analyze the long-term effects of DBS and expand therapeutic targets in the brain. This will further personalize th...
Read moreA study published in Nature Nanotechnology presents an innovative graphene-based neurotechnology with the potential for a transformative impact in neuroscience and medical applications.
Read moreResearchers at the UPF Center for Brain and Cognition (CBC) and the Visualization, Virtual Reality and Graphics Interaction (ViRVIG) research group at the UdG have driven this study, which reveals new...
Read moreUn estudio abre la posibilidad al desarrollo de nuevas terapias para mejorar el neurodesarrollo infantil mediante el uso de compuestos o microorganismos probióticos
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreInvestigadores de las universidades de Cádiz y Sevilla han identificado que un fármaco, que se utiliza en la actualidad para el tratamiento de cáncer de pulmón, facilita la repoblación con nuevas...
Read moreA research team from the University of Barcelona (UB) is taking part in a consortium to develop new therapeutic targets for diseases of the central nervous system, such as neurodegenerative pathologie...
Read more